Doctor profile · Federal record
Dr. ALI MOUSSA, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · TULSA, OK
- NPI 1548207814
- Accepts Medicare
- MIPS 82.5 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12697 E 51ST ST
TULSA, OK 741466236
(918) 505-3200
fax (918) 505-3253
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- September 2, 2020
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Oklahoma #21439
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548207814. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
104,012
Distinct HCPCS
10
Medicare allowed
$1,985,474
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 26,250 | 27 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 13,590 | 19 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 12,120 | 14 | $28 | |
J9271 |
Injection, pembrolizumab, 1 mg | 11,400 | 19 | $54 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 5,600 | 30 | $5 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,800 | 43 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 3,770 | 20 | $1 | |
J1449 |
Injection, eflapegrastim-xnst, 0.1 mg | 2,904 | 15 | $32 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,820 | 82 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,952 | 745 | $8 |
In context: peer comparison
Among 18 peers in this city , average services per provider: 1,283. This provider delivers 81× the peer median.Open Payments
Industry payments received
All-time total
$540
Transactions
22
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $140.31 | |
| BeiGene USA, Inc. | 4 | $80.87 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52.35 | |
| PFIZER INC. | 2 | $39.17 | |
| Daiichi Sankyo Inc. | 2 | $39.08 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.82 | |
| GlaxoSmithKline, LLC. | 2 | $33.78 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $28.96 | |
| Aveo Pharmaceuticals, Inc. | 1 | $21.14 | |
| Lilly USA, LLC | 1 | $19.48 | |
| Incyte Corporation | 1 | $16.95 | |
| Genentech USA, Inc. | 1 | $15.64 | |
| Astellas Pharma US Inc | 1 | $13.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,233
Patients
660
Total drug cost
$3,095,212
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 412 | 86 | $18,298 |
| Ondansetron Hcl | Generic | 198 | 107 | $5,485 |
| Prochlorperazine Maleate | Generic | 189 | 93 | $2,394 |
| Levothyroxine Sodium | Generic | 177 | 44 | $2,219 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 174 | 60 | $3,451 |
| Alendronate Sodium | Generic | 168 | 33 | $1,897 |
| Potassium Chloride | Generic | 145 | 37 | $3,585 |
| Prednisone | Generic | 138 | 38 | $1,049 |
| Dexamethasone | Generic | 134 | 46 | $3,287 |
| Duloxetine Hcl | Generic | 105 | 20 | $1,264 |